Arcus Biosciences (RCUS) Capital Expenditures Growth (3y) (2020 - 2025)
Arcus Biosciences (RCUS) Capital Expenditures Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arcus Biosciences |
3.05 Bn |
2.23 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2025 |
0.00% |
| Dec 31, 2024 |
27.25% |
| Sep 30, 2024 |
-55.15% |
| Jun 30, 2024 |
-6.79% |
| Mar 31, 2024 |
-28.92% |
| Dec 31, 2023 |
-98.38% |
| Sep 30, 2023 |
319.97% |
| Jun 30, 2023 |
274.46% |
| Mar 31, 2023 |
143.03% |
| Sep 30, 2022 |
55.30% |
| Jun 30, 2022 |
55.43% |
| Mar 31, 2022 |
38.06% |
| Dec 31, 2021 |
-87.13% |
| Sep 30, 2021 |
142.50% |
| Jun 30, 2021 |
128.12% |
| Mar 31, 2021 |
58.82% |
| Dec 31, 2020 |
-20.54% |
| Sep 30, 2020 |
31.73% |
| Jun 30, 2020 |
45.30% |
| Mar 31, 2020 |
-42.51% |
